Tag: Microsoft investment

Browse our exclusive articles!

Non-Profit’s $10 Billion Microsoft Investment Sparks Governance Concerns

Discover the concerns and debates surrounding OpenAI's $10 billion investment from Microsoft, raising questions about governance and transparency.

OpenAI Co-founder Sam Altman Fired Over Communication Issues

Sam Altman fired from OpenAI due to communication issues, following Microsoft's $10 billion investment. Impact on OpenAI's future direction remains uncertain.

Sam Altman Responds to Elon Musk’s OpenAI Criticism

CEO of OpenAI, Sam Altman is rejecting Elon Musk's accusations of being profit-driven over safety. Altman dismissed Musk's allegations as baseless and defended OpenAI's proactive approach towards tackling AI safety issues. The ongoing debate highlights divergent perspectives within the AI community.

OpenAI CEO Sam Altman Aims for Freedom to Make Unconventional Decisions, Opposes Going Public.

OpenAI won't go public, says CEO Sam Altman, as he wants to maintain control over the company's technology. Altman anticipates making decisions that may conflict with public investors' views. With its creative and less biased GPT-4 model, OpenAI received a $10bn investment from Microsoft, valuing the startup at $29bn.

Sam Altman of OpenAI declines in-person meeting with PM Netanyahu in Israel visit

OpenAI CEO, Sam Altman, reportedly refused an in-person meeting with Israeli Prime Minister Benjamin Netanyahu due to the latter's controversial plans to overhaul the country's judiciary, which is opposed by the high-tech sector. Despite this, Altman spoke to Netanyahu over the phone about AI opportunities and challenges, and the possibility of cooperation. OpenAI received significant investment from Microsoft and launched GPT-3, Dall-E, and ChatGPT. Altman is currently in Israel for a lecture at Tel Aviv University.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img